
Vælg din etiket
vises direkte på hætteglassetLaboratorierapport
PDF- Testet
- Thymosin Alpha-1 5mg
- Laboratorium
- Analiza Białek
- Dato
- November 2026
- Resultat
- 99% purity (5.33 mg measured)
- Endotoksiner
- 4.56 EU/vial
- Ordrenr.
- Adgangskode
Uafhængigt testet, kan verificeres med adgangskoden direkte hos laboratoriet.
Thymosin Alpha-1
Immune System
- Laboratorietestet · 99% renhed
- Sendes fra Tyskland
Bestilling
- DHL med sporing
- Diskret emballage
Kort fortalt
Thymosin Alpha-1 i tal
Nøgletallene fra vores leksikon.
Hele leksikonopslaget- Class
- Immune-modulating peptidethymus-derived
- Frequency
- ~2x per weekin phases
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
The source in the lexiconRandomized controlled study of thymosin alpha-1 in severe sepsis (ETASS) (opens in a new tab)
Wu et al., Critical Care, 2013
Anmeldelser
Hvad kunderne siger
Kun rigtige bestillinger, der indeholdt Thymosin Alpha-1.
Alle anmeldelserViden
Alt om Thymosin Alpha-1
Detaljerede oplysninger kommer snart.
Dosering
Indlæser doseringsinformation …
Godt at have
Det har du brug for til den
Bakteriostatisk vand lægges automatisk i din kurv. Sprøjter og servietter med ét klik.
Insulinsprøjter
10 stk. · 5.50 €
Spritservietter
50 stk. · 10 €
Hvor meget vand?
Enheder på sprøjten til din hætteglasstørrelse.
Åbn beregneren →Is Thymosin Alpha-1 approved?
Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.
How does Thymosin Alpha-1 work?
In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.
What do the sepsis trials show?
In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.
Are there data on cancer?
In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.
Does it help in severe pancreatitis?
Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.
Which side effects are known?
In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.
Relateret
Relaterede produkter
Thymalin
Peptider · Immunforsvar Immunforsvar
2 størrelser
= fra 16 €/hætteglas
KPV
Peptider · Immunforsvar Immunforsvar
4 størrelser
Laboratorietestet
= fra 11.6 €/hætteglas
VIP
Peptider · Immunforsvar Immunforsvar
2 størrelser
= fra 23.2 €/hætteglas
VIP Nasal
Peptider · Immunforsvar Immunforsvar
1 størrelse
Thymosin Alpha-1